After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?
West Monroe featured on Benzinga
Date : February 6, 2015

2014 was a banner year for mergers and acquisitions globally, but few sectors dominated the deal-making cycle like pharmaceuticals and biotech.

According to Bloomberg data, drug makers announced a record $234 billion in acquisitions last year, nearly triple 2013 volumes.

The year was marked by a string of mega-deals and serial acquirers, from Medtronic's $42.9 billion purchase of medical device manufacturer Covidien multibillion buys of Forest Laboratories and Allergan. Barely a month in to 2015, the industry shows no signs of sweating out the M&A bug.

West Monroe takes a look at the primary drivers behind pharmaceutical and biotech deals in 2014, and what they indicate for M&A over the next twelve months. Click here to view the article as it originally appeared on Benzinga.


Martin Glenn joins West Monroe Partners’ Mergers & Acquisitions practice
View More
Related News
Author:
Date : February 2, 2017
Will Hinde explains how healthcare organizations can best utilize communication technology to improve patients' customer experience via Healthcare Business News.
Industry:
Author:
Date : February 1, 2017

Healthcare organizations need to “know” and understand consumers better—and that, in turn, requires mining all available consumer data. But organizations must also understand the security risk inherent in data collection and make sure the CISO has a seat at the strategy table. 

Service:
Industry:
West Monroe Partners adds healthcare expertise to its local office leadership team as strong demand fuels growth.
Author:
Date : January 17, 2017


Industry: